EAM
IART icon

Eagle Asset Management’s Integra LifeSciences IART Stock Holding History

Eagle Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-245,841
Closed -$7.12M – 561
2024
Q2 		$7.12M Sell
245,841
-72,889
-23% -$2.16M 0.04% 348
2024
Q1 		$11.1M Buy
318,730
+20,929
+7% +$837K 0.06% 273
2023
Q4 		$13M Buy
297,801
+11,992
+4% +$472K 0.07% 238
2023
Q3 		$10.9M Buy
285,809
+10,069
+4% +$424K 0.06% 247
2023
Q2 		$11.3M Buy
275,740
+58,420
+27% +$2.81M 0.06% 244
2023
Q1 		$12.5M Buy
217,320
+81,145
+60% +$4.57M 0.07% 217
2022
Q4 		$7.59M Sell
136,175
-2,563
-2% -$130K 0.05% 271
2022
Q3 		$5.88M Buy
138,738
+44,996
+48% +$2.31M 0.04% 309
2022
Q2 		$5.06M Sell
93,742
-198
-0.2% -$11.9K 0.03% 349
2022
Q1 		$6.04M Sell
93,940
-5,459
-5% -$359K 0.03% 362
2021
Q4 		$6.8M Sell
99,399
-139,792
-58% -$9.46M 0.03% 366
2021
Q3 		$16.4M Sell
239,191
-65,544
-22% -$4.63M 0.07% 239
2021
Q2 		$20.8M Buy
304,735
+2,339
+0.8% +$165K 0.09% 232
2021
Q1 		$20.6M Buy
302,396
+28,808
+11% +$1.95M 0.09% 239
2020
Q4 		$17.8M Sell
273,588
-74,702
-21% -$4.02M 0.1% 230
2020
Q3 		$16.2M Buy
348,290
+12,435
+4% +$592K 0.08% 229
2020
Q2 		$15.6M Buy
335,855
+35,891
+12% +$1.76M 0.09% 236
2020
Q1 		$13.4M Buy
299,964
+40,418
+16% +$2.12M 0.08% 238
2019
Q4 		$15.1M Buy
259,546
+41,750
+19% +$2.49M 0.07% 254
2019
Q3 		$13.1M Sell
217,796
-3,826
-2% -$228K 0.07% 267
2019
Q2 		$12.4M Sell
221,622
-4,081
-2% -$210K 0.06% 278
2019
Q1 		$12.6M Buy
225,703
+1,359
+0.6% +$69.2K 0.07% 272
2018
Q4 		$10.1M Buy
224,344
+9,380
+4% +$515K 0.06% 292
2018
Q3 		$14.2M Buy
214,964
+45,350
+27% +$2.82M 0.07% 291
2018
Q2 		$10.9M Buy
169,614
+7,994
+5% +$495K 0.06% 314
2018
Q1 		$8.94M Sell
161,620
-1,476
-0.9% -$77.4K 0.05% 332
2017
Q4 		$7.89M Buy
163,096
+2,237
+1% +$109K 0.04% 358
2017
Q3 		$8.16M Sell
160,859
-1,486,159
-90% -$76.3M 0.05% 361
2017
Q2 		$89.8M Buy
1,647,018
+461,977
+39% +$22.1M 0.54% 36
2017
Q1 		$49.9M Buy
1,185,041
+189,049
+19% +$8.08M 0.31% 95
2016
Q4 		$42.7M Buy
995,992
+877,610
+741% +$35.7M 0.28% 115
2016
Q3 		$4.89M Sell
118,382
-28,766
-20% -$1.21M 0.03% 410
2016
Q2 		$5.87M Buy
147,148
+5,084
+4% +$183K 0.04% 390
2016
Q1 		$4.78M Sell
142,064
-27,784
-16% -$865K 0.03% 407
2015
Q4 		$5.76M Sell
169,848
-6,526
-4% -$204K 0.04% 387
2015
Q3 		$5.25M Sell
176,374
-41,308
-19% -$1.29M 0.04% 403
2015
Q2 		$5.99M Buy
217,682
+92,293
+74% +$2.46M 0.03% 402
2015
Q1 		$3.16M Sell
125,389
-15,963
-11% -$377K 0.02% 474
2014
Q4 		$3.13M Sell
141,352
-29,341
-17% -$595K 0.02% 486
2014
Q3 		$3.46M Sell
170,693
-1,296
-0.8% -$25.8K 0.02% 498
2014
Q2 		$3.31M Sell
171,989
-5,199
-3% -$96.9K 0.02% 527
2014
Q1 		$3.33M Sell
177,188
-47,821
-21% -$923K 0.02% 549
2013
Q4 		$4.39M Sell
225,009
-1,148
-0.5% -$21.1K 0.02% 458
2013
Q3 		$3.69M Sell
226,157
-2,640
-1% -$42.4K 0.02% 543
2013
Q2 		$3.42M Buy
+228,797
New +$3.35M 0.02% 522

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eagle Asset Management's IART Position: Q3 2024 in Review

Eagle Asset Management sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 245,841 shares — an estimated $7.12M sold.

Eagle Asset Management first reported a position in IART in Q2 2013 and held it in 45 quarters. The position peaked at $89.8M in Q2 2017. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Eagle Asset Management reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Eagle Asset Management sold 245,841 Integra LifeSciences shares in Q3 2024, an estimated $7.12M.
  • Eagle Asset Management first reported a position in Integra LifeSciences in Q2 2013 and held it in 45 quarters.
  • Eagle Asset Management's Integra LifeSciences position peaked at $89.8M in Q2 2017.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.